Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.7%

2 terminated out of 54 trials

Success Rate

95.7%

+9.2% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

0%

0 of 44 completed with results

Key Signals

96% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (3)
Early P 1 (2)
P 1 (48)
P 4 (1)

Trial Status

Completed44
Unknown7
Terminated2
Recruiting1

Trial Success Rate

95.7%

Benchmark: 86.5%

Based on 44 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT07479745Phase 1RecruitingPrimary

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

NCT07015918Phase 1CompletedPrimary

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

NCT04534582Phase 1CompletedPrimary

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

NCT05105425Not ApplicableCompletedPrimary

The Effects of Daily Supplementation of Nutriose® on the Fecal Microbiota in Volunteers.

NCT06381869Not ApplicableCompletedPrimary

Bioavailability of Pea Protein in Young and Old Volunteers

NCT06159101Phase 1UnknownPrimary

A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects

NCT05981963Phase 1CompletedPrimary

A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

NCT05523687Phase 1CompletedPrimary

AME Study of [14C]-PC14586 in Healthy Male Participants

NCT03089112Phase 1CompletedPrimary

Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501

NCT05475834Phase 1CompletedPrimary

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

NCT04411550Phase 1CompletedPrimary

Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects

NCT03863587Phase 1TerminatedPrimary

Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adult Subjects

NCT04810533Phase 1CompletedPrimary

The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers

NCT04808648Phase 1UnknownPrimary

The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

NCT04633733Phase 1UnknownPrimary

The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

NCT04086719Phase 1CompletedPrimary

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

NCT04490434Phase 1UnknownPrimary

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

NCT04476394Phase 1UnknownPrimary

Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects

NCT04467060Phase 1CompletedPrimary

A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

NCT04463173Phase 1CompletedPrimary

Food Effect Study of Anaprazole in Healthy Chinese Subjects

Scroll to load more

Research Network

Activity Timeline